Sugentech Inc
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2… Read more
Market Cap & Net Worth: Sugentech Inc (253840)
Sugentech Inc (KQ:253840) has a market capitalization of $53.15 Million (₩77.82 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21757 globally and #1054 in its home market, demonstrating a 5.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sugentech Inc's stock price ₩5090.00 by its total outstanding shares 15289668 (15.29 Million).
Sugentech Inc Market Cap History: 2019 to 2026
Sugentech Inc's market capitalization history from 2019 to 2026. Data shows change from $55.27 Million to $53.15 Million (-9.18% CAGR).
Index Memberships
Sugentech Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.03% | #491 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.03% | #491 of 1384 |
Weight: Sugentech Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sugentech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sugentech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Sugentech Inc's market cap is 0.01 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $55.27 Million | $3.85 Billion | -$9.56 Billion | 0.01x | N/A |
| 2020 | $204.74 Million | $41.35 Billion | -$41.02 Billion | 0.00x | N/A |
| 2021 | $141.20 Million | $77.20 Billion | $36.15 Billion | 0.00x | 0.00x |
| 2022 | $103.93 Million | $101.40 Billion | $26.72 Billion | 0.00x | 0.00x |
| 2023 | $80.93 Million | $7.13 Billion | -$17.24 Billion | 0.01x | N/A |
| 2024 | $55.66 Million | $10.10 Billion | -$15.19 Billion | 0.01x | N/A |
Competitor Companies of 253840 by Market Capitalization
Companies near Sugentech Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Sugentech Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Sugentech Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Sugentech Inc's market cap moved from $55.27 Million to $ 53.15 Million, with a yearly change of -9.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩53.15 Million | -17.10% |
| 2025 | ₩64.12 Million | +15.20% |
| 2024 | ₩55.66 Million | -31.23% |
| 2023 | ₩80.93 Million | -22.13% |
| 2022 | ₩103.93 Million | -26.39% |
| 2021 | ₩141.20 Million | -31.03% |
| 2020 | ₩204.74 Million | +270.44% |
| 2019 | ₩55.27 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sugentech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $53.15 Million USD |
| MoneyControl | $53.15 Million USD |
| MarketWatch | $53.15 Million USD |
| marketcap.company | $53.15 Million USD |
| Reuters | $53.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.